Effect of PPAR-gamma Agonist Rosiglitazone on Bone Mineral Density and Serum Adipokines in C57BL/6 Male Mice

Abstrakt

Anotation: Rosiglitazone causes a loss of bone mass in cortical bone, possibly through a decrease in bone formation.

Klíčová slova

• Rosiglitazone
• bone metabolism
• adipokines